Efficacy and safety of commercialized fecal microbiota transplant for the treatment of recurrent Clostridioides difficile infection
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
Infection, disease & health - 28(2023), 1 vom: 23. Feb., Seite 71-73 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yendrapalli, Usha [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clostridioides difficile |
|---|
| Anmerkungen: |
Date Completed 17.01.2023 Date Revised 14.02.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.idh.2022.06.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343910632 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343910632 | ||
| 003 | DE-627 | ||
| 005 | 20231226021537.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.idh.2022.06.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1146.xml |
| 035 | |a (DE-627)NLM343910632 | ||
| 035 | |a (NLM)35871158 | ||
| 035 | |a (PII)S2468-0451(22)00044-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yendrapalli, Usha |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Efficacy and safety of commercialized fecal microbiota transplant for the treatment of recurrent Clostridioides difficile infection |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.01.2023 | ||
| 500 | |a Date Revised 14.02.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Clostridioides difficile | |
| 650 | 4 | |a Commercialized FMT | |
| 650 | 4 | |a Fecal microbiota transplant | |
| 700 | 1 | |a Edwards, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a Belk, Madeline |e verfasserin |4 aut | |
| 700 | 1 | |a Steuber, Taylor |e verfasserin |4 aut | |
| 700 | 1 | |a Hassoun, Ali |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Infection, disease & health |d 2017 |g 28(2023), 1 vom: 23. Feb., Seite 71-73 |w (DE-627)NLM291105580 |x 2468-0869 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2023 |g number:1 |g day:23 |g month:02 |g pages:71-73 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.idh.2022.06.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2023 |e 1 |b 23 |c 02 |h 71-73 | ||